Procore is a biotechnology company singly focused on developing solutions that improve the quality of lives of patients suffering from joint and bone diseases. The company’s flagship RegenoGel family is based on proprietary HAProLink technology, a platform technology that links hyaluronic acid to a protein of choice to create a microenvironment for the body to heal itself via natural, gentle cartilage and bone regeneration. RegenoGel products are approved by Israel’s Ministry of Health and have been commercially available since 2016. RegenoGel and the company’s platform technologies are based on the seminal work in biomimetic innovation of Prof. Avner Yayon’s, Procore’s founder.
Company Details
- Employees
- 6
- Address
- 7 Golda Meir St., Ness Ziona,israel
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://regenogel.co.il/
- Keywords
- (R.A).
- HQ
- Ness Ziona
Procore Ltd Questions
Procore Ltd's website is https://regenogel.co.il/
Procore Ltd's LinkedIn profile is https://il.linkedin.com/company/procore-ltd
Procore Ltd has
6 employees.
View email and phone details for 6
employees at Procore Ltd.
Procore Ltd's industry is
Biotechnology Research
Procore Ltd's top competitors are
Procore Solutions,
Cande S.r.o.,
Xtramed Egypt,
Procore Technologies,
Pharma Tamar,
The Galilee Society – The Arab National Society For Health Research And Services (R.a),
Polyclinic Bonifarm,
Amedia Group,
Hcs,
Geffen Medical.
Procore Ltd's categories are Biotechnology Research
